Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Sonocine
AddedFeb 15, 2024
UpdatedJun 18, 2026
Sonocine

Sonocine

Sonocine, Inc. develops advanced medical systems for disease treatment and diagnostic imaging in the US.

HQ
Reno, NV, US
Founded
2000
Overview
Compare
Fundraising
Employees
Website

Sonocine, Inc. develops advanced medical systems for breast cancer screening and diagnostic imaging. Their flagship product, SonoCiné AWBUS (Automated Whole Breast Ultrasound), is designed to complement mammography, particularly for women with dense breast tissue. The company focuses on improving early detection rates and providing more comprehensive breast imaging solutions for healthcare providers in the United States.

The SonoCiné technology has demonstrated success in detecting cancers missed by traditional mammography, as evidenced by testimonials from medical professionals like Dr. Daniel Herron. By offering an additional screening option, Sonocine aims to enhance breast cancer detection rates and potentially save lives through earlier diagnosis. The company provides resources for patients and doctors to learn about their technology and locate SonoCiné providers.

Sonocine - Similar Companies

Delphinus Medical Technologies logo

Delphinus Medical Technologies

delphinusmt.com

Physiosonics logo

Physiosonics

Sonex Health logo

Sonex Health

sonexhealth.com

SonoSolve logo

SonoSolve

Clarisond logo

Clarisond

Sonavex logo

Sonavex

sonavex.com

Sonomotion logo

Sonomotion

sonomotion.com

SonoVascular logo

SonoVascular

sonovascular.com

Gynesonics logo

Gynesonics

gynesonics.com

Pharmasonics logo

Pharmasonics

Exo logo

Exo

exo.inc

Sonitus Medical logo

Sonitus Medical

sonitusmedical.com

Portela Soni Medical logo

Portela Soni Medical

Sonde Health logo

Sonde Health

sondehealth.com

Sonogen Medical logo

Sonogen Medical

sonogenmed.com

Sonocine - Quick Facts

Who are Sonocine's competitors?

Companies similar to Sonocine include Delphinus Medical Technologies, Physiosonics, Sonex Health and SonoSolve.

When was Sonocine founded?

Sonocine was founded in 2000.

Where is Sonocine's headquarters located?

Sonocine's headquarters is located in Reno, NV, US.

When was Sonocine's last funding round?

Sonocine's most recent funding round was for $7.1M (USD) in February 2015.

How much has Sonocine raised to-date?

As of Feb 9, 2015, Sonocine has raised a total of $14.2M (USD).

How many employees does Sonocine have?

Sonocine has 30 employees as of Feb 5, 2024.

Sonocine - Classification

Industry
  • Hardware
  • Medical Devices
Technology
  • Ultrasound
Geographic Exposure
  • United States
Revenue
  • Recurring
  • Transactional
Main Product
  • Breast Imaging
  • Medical Systems
Tags
  • Healthcare Providers
  • Healthtech
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 325000Chemical Manufacturing
  • 325410Pharmaceutical and Medicine Manufacturing
SIC
  • 5000Wholesale Trade-durable Goods
  • 5040Professional And Commercial Equipment And Supplies
  • 5047Medical, Dental, And Hospital Equipment And Supplies
Show 7 more industry codes
NAICS
  • 330000Manufacturing
  • 620000Health Care and Social Assistance
  • 623000Nursing and Residential Care Facilities
SIC
  • 3900Miscellaneous Manufacturing Industries
  • 8000Health Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified